Mary T. Korytkowski MD
Emeritus Professor of Medicine, Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PennsylvaniaDr. Mary Korytkowski is a professor of medicine at the University of Pittsburgh School of Medicine. She received her medical degree from the University of North Carolina at Chapel Hill. She completed her residency in internal medicine at Baltimore City Hospital (now named Bayview Medical Center). She completed her post-doctoral fellowship in endocrinology and metabolism at Johns Hopkins University Hospital and Sinai Hospital of Baltimore.
Dr. Korytkowski has over 100 publications relating to her areas of research interest that include contributors to insulin resistance in individuals with or at risk for type 2 diabetes; interventions that promote glycemic and metabolic control in these groups; and inpatient glycemic management.
She currently serves on ABIM Endocrinology Board’s Examination Writing Committee.
Positions:
Professor of Medicine, University of Pittsburgh School of Medicine
Degrees:
Masters in Nursing: Emory University
MD: University of North Carolina at Chapel Hill
Postgraduate Training:
Johns Hopkins University Hospital and Sinai Hospital of Baltimore
Clinical Interests:
Diabetes, thyroid disorders, polycystic ovary syndrome, general endocrinology
Disclosures
1. Receive(d) an Investigator Initiated Research Grant from: Sanofi (2011-2013)
Recent Contributions to PracticeUpdate:
- Effectiveness and Safety of New Oral and Injectable Agents for In-Hospital Management of Type 2 Diabetes in General Wards
- Inpatient Hypoglycemia: Understanding Who Is at Risk
- Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
- Early Intervention for Diabetes Inpatients Decreases Hyperglycemia and Hospital-Acquired Infections
- Efficacy of Sitagliptin for the Hospital Management of General Medicine and Surgery Patients With Type 2 Diabetes
- HbA1c at Admission Guides Management of Patients With Type 2 Diabetes at Discharge
- Readmission and ED Use in Patients With Severely Uncontrolled Type 2 Diabetes